Lastly, more studies of Eph and ephrin expression and activity in human tumours are required to evaluate Eph- and tumour-specific connections to disease progression, drug resistance, and patient survival, as well as identify other potential biomarkers of response. Here, EPHA1 is linked to neoplasm.